News Announcement

Jagsonpal Pharmaceuticals: Board Meeting Outcome for Outcome Of Board Meeting Held On January 21 2026 Along With Unaudited Financial Results For TheQuarter And Nine Months Ended December 31 2025

Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 of the Securities and Exchange Board ofIndia (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Boardof Directors at its Meeting held today inter-alia considered and approved the Unaudited Financial Results for the quarterand nine months ended December 31 2025.

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.